Want to improve your sleep in 2025? These new science-based tips may help.
New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...
Woman ‘suicidal’ after taking same antidepressants as Thomas Kingston issues warning over side effects
A woman who said she has become severely suicidal during a year of being prescribed the same antidepressants as royal family ...
Smithsonian Magazine2d
In a Study on Mice, Scientists Show How the Brain Washes Itself During Sleep
The brain's waste-removal process is "like turning on the dishwasher," a neurologist says, but common sleep medications may ...
Early study reveals why sleeping pills may not supply the best-quality snooze
A new study in mice suggests that sleeping pills may impede the brain's ability to "cleanse" itself during sleep.
FDA approves first ever medication for obstructive sleep apnea — here's what that means
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
Health and Me on MSN5d
Experiencing A Lack Of Sleep? This Medication May Be The Cause Of It
While we have made a lot of progress in the medical field, people at have started relying on it more than necessary. Although ...
Medscape15d
A Qualitative Investigation of Long-term Zopiclone Use and Sleep Quality among Vietnam War Veterans with PTSD
Moreover, although actigraphy was used to assess sleep efficiency ... among Vietnam War veterans who are long-term users of the drug. The cohort was drawn from a population with intimate and ...
Everyday Health15d
FDA Approves First Medication for Obstructive Sleep Apnea
The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...
KSL16d
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug to get the green light to ...
The Spokesman-Review17d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the ...
New York Post17d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...